These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 7034303)

  • 1. Antihypertensive agents: role of therapeutic drug monitoring.
    Moyer TP; Sheps SG
    Ther Drug Monit; 1981; 3(3):217-30. PubMed ID: 7034303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preventing, detecting and managing adverse reactions of antihypertensive agents in the ambulant patient with essential hypertension.
    Riddiough MA
    Am J Hosp Pharm; 1977 May; 34(5):465-79. PubMed ID: 326040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complications of antihypertensive therapy.
    Shapiro AP; Traub YM
    Am Fam Physician; 1981 Mar; 23(3):155-63. PubMed ID: 7468405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of antihypertensive therapy on sympathetic nervous system activity in patients with essential hypertension.
    Chernow B; Zaloga GP; Lake CR; Coleman MD; Ziegler MG
    Fed Proc; 1984 Jan; 43(1):72-7. PubMed ID: 6317467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Older blood pressure medications-do they still have a place?
    Slim HB; Black HR; Thompson PD
    Am J Cardiol; 2011 Jul; 108(2):308-16. PubMed ID: 21550576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using pharmacokinetics in drug therapy. V: Contributions to developing dosage regimens for antihypertensive drugs.
    Schumacher GE
    Am J Hosp Pharm; 1979 Sep; 36(9):1222-6. PubMed ID: 386789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical pharmacology of antihypertensive drugs.
    Nies AS
    Med Clin North Am; 1977 May; 61(3):675-98. PubMed ID: 16188
    [No Abstract]   [Full Text] [Related]  

  • 8. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
    Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA
    J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update of diuretics in the treatment of hypertension.
    Padilla MC; Armas-Hernández MJ; Hernández RH; Israili ZH; Valasco M
    Am J Ther; 2007; 14(2):154-60. PubMed ID: 17414583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Are all antihypertensive drugs renoprotective?].
    Wolf S; Risler T
    Herz; 2004 May; 29(3):248-54. PubMed ID: 15167950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of three antihypertensive drug groups on lipid metabolism. Effects of alpha receptor blockers, central sympatholytic drugs and vasodilators].
    Jacob BG; Richter WO; Schwandt P
    Fortschr Med; 1993 Mar; 111(8):126-9. PubMed ID: 8099558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharmacology of antihypertensive agents].
    Torsti P
    Duodecim; 1974; 90(9):703-11. PubMed ID: 4609031
    [No Abstract]   [Full Text] [Related]  

  • 13. Antihypertensive drugs that alter adrenergic function.
    Weinshilboum RM
    Mayo Clin Proc; 1980 Jun; 55(6):390-402. PubMed ID: 6103981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of hypertension in chronic kidney disease.
    Toto RD
    Semin Nephrol; 2005 Nov; 25(6):435-9. PubMed ID: 16298269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Considerations in the long-term treatment of hypertension.
    Graham RM
    Clin Ther; 1983; 5(3):224-33. PubMed ID: 6342783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The future of antihypertensive treatment.
    Israili ZH; Hernández-Hernández R; Valasco M
    Am J Ther; 2007; 14(2):121-34. PubMed ID: 17414579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends in antihypertensive drugs in the elderly: the decline of thiazides.
    Onder G; Gambassi G; Landi F; Pedone C; Cesari M; Carbonin PU; Bernabei R;
    J Hum Hypertens; 2001 May; 15(5):291-7. PubMed ID: 11378830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Management of hypertension in children].
    Peco-Antić A; Pejcić I
    Srp Arh Celok Lek; 1995; 123(9-10):274-7. PubMed ID: 17974448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Profile on circadian blood pressure and the influencing factors in essential hypertensive patients after treatment].
    Qiu YG; Yao XY; Tao QM; Zheng P; Chen JZ; Zhu JH; Zhang FR; Zheng LR; Zhao LL
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Aug; 25(8):710-4. PubMed ID: 15555399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The 2004 Canadian recommendations for the management of hypertension: Part II--Therapy.
    Khan NA; McAlister FA; Campbell NR; Feldman RD; Rabkin S; Mahon J; Lewanczuk R; Zarnke KB; Hemmelgarn B; Lebel M; Levine M; Herbert C;
    Can J Cardiol; 2004 Jan; 20(1):41-54. PubMed ID: 14968142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.